User profiles for Jacqueline Miot

Jacqui Miot

Health Economics and Epidemiology Research Office, University of Witwatersrand
Verified email at heroza.org
Cited by 875

[HTML][HTML] Medicines regulation in Africa: current state and opportunities

M Ndomondo-Sigonda, J Miot, S Naidoo… - Pharmaceutical …, 2017 - Springer
Sound regulatory systems are critical for protecting public health against use of medical
products which do not meet international standards of quality, safety and efficacy. This review …

The African medicines regulatory harmonization initiative: progress to date

M Ndomondo-Sigonda, J Miot, S Naidoo… - Medical Research …, 2018 - esmed.org
The African Medicines Regulatory Harmonization Initiative (AMRH) has contributed to reduce
marketing authorization timelines in East African Community and the Southern African …

[HTML][HTML] Harmonization of medical products regulation: a key factor for improving regulatory capacity in the East African Community

M Ndomondo-Sigonda, J Miot, S Naidoo, NE Masota… - BMC Public Health, 2021 - Springer
Background Limited capacity to regulate medical products is associated with circulation of
products which do not meet standards of quality, safety and efficacy with negative public …

Community health worker models in South Africa: a qualitative study on policy implementation of the 2018/19 revised framework

…, S Mngadi, N Ngcobo, J Miot… - Health Policy and …, 2021 - academic.oup.com
South Africa has a long history of community health workers (CHWs). It has been a journey
that has required balancing constrained resources and competing priorities. CHWs form a …

[HTML][HTML] A situational analysis of current antimicrobial governance, regulation, and utilization in South Africa

…, K Faure, D Goff, M Mendelson, J Meyer, J Miot… - International journal of …, 2017 - Elsevier
The Global Action Plan on antimicrobial resistance calls for the use of antimicrobial
medicines in human and animal health to be optimized, in tandem with a strengthening of the …

[HTML][HTML] Reduction in initiations of HIV treatment in South Africa during the COVID pandemic

…, S Rosen, G Meyer-Rath, JM Tucker, J Miot - BMC Health Services …, 2022 - Springer
Background In response to the global pandemic of COVID-19, countries around the world
began imposing stay-at-home orders, restrictions on transport, and closures of businesses in …

[HTML][HTML] Applying machine learning and predictive modeling to retention and viral suppression in South African HIV treatment cohorts

…, T Crompton, J Bor, M Rennick, A Chirowodza, J Miot… - Scientific reports, 2022 - nature.com
HIV treatment programs face challenges in identifying patients at risk for loss-to-follow-up
and uncontrolled viremia. We applied predictive machine learning algorithms to anonymised, …

[HTML][HTML] Field testing of a multicriteria decision analysis (MCDA) framework for coverage of a screening test for cervical cancer in South Africa

J Miot, M Wagner, H Khoury, D Rindress… - Cost Effectiveness and …, 2012 - Springer
Background Systematic and transparent approaches to priority setting are needed,
particularly in low-resource settings, to produce decisions that are sound and acceptable to …

Introducing health technology assessment in Tanzania

…, K Chalkidou, W Reuben, F Suleman, J Miot… - International journal of …, 2020 - cambridge.org
ObjectivesHealth technology assessment (HTA) is a cost-effective resource allocation tool
in healthcare decision-making processes; however, its use is limited in low-income settings …

[HTML][HTML] National medicines regulatory authorities financial sustainability in the East African Community

M Ndomondo-Sigonda, J Miot, S Naidoo, B Ng'andu… - PLoS …, 2020 - journals.plos.org
Introduction Adequate and sustainable funding of national medicine regulatory agencies (NMRAs)
is key for assurance of quality, safety and efficacy of medical products circulating in a …